SCHEMBL22005648

SCHEMBL22005648

Cc1ccc(C(=O)OCc2ccccc2)n1C

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.53
KMT2A Q03164 3/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
ALDH1A1 P00352 7/20 0.50
LMNA P02545 1/20 0.49
MAPT P10636 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 3/20 0.46
TSHR P16473 2/20 0.46
CYP3A4 P08684 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
RAB9A P51151 5/20 0.45
NPC1 O15118 3/20 0.45
STAT1 P42224 1/20 0.45
POLB P06746 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705870 0.86 TDP1 (0.54) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL2707500 0.81 TDP1 (0.49) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL8002346 0.80 HPGD (0.50) KMT2AALDH1A1LMNAMAPTHPGD
SCHEMBL22005507 0.78 ALDH1A1 (0.52) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL19928034 0.78 MAPT (0.57) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL10225709 0.76 TDP1 (0.48) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL20201248 0.76 NPC1 (0.72) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL17965761 0.75 TDP1 (0.61) TDP1KMT2ASLC6A2SLC6A3ALDH1A1
SCHEMBL22258127 0.75 MCL1 (0.60) TDP1KMT2ASLC6A2SLC6A3
SCHEMBL18760785 0.75 TDP1 (0.56) TDP1KMT2ASLC6A2SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2023-11-09 US disclosed
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2023-11-09 US disclosed
US-10874645-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL CORPORATION (JP) 2020-12-29 US disclosed
US-20200155511-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE HDAC7, ACHE, BRDT TDP1 3193/4885KMT2A 342/4885SLC6A2 633/4885
US-10874645-B2 Isoxazoline-substituted benzamide compound and pesticide C3AR1, C5, C9 TDP1 4037/4885KMT2A 2752/4885SLC6A2 1623/4885
US-20200155511-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE C3AR1, C5, C9 TDP1 4037/4885KMT2A 2752/4885SLC6A2 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.